GENESA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Genesa, and when can generic versions of Genesa launch?
Genesa is a drug marketed by Gensia Automedics and is included in one NDA.
The generic ingredient in GENESA is arbutamine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the arbutamine hydrochloride profile page.
US Patents and Regulatory Information for GENESA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gensia Automedics | GENESA | arbutamine hydrochloride | INJECTABLE;INJECTION | 020420-001 | Sep 12, 1997 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for GENESA
See the table below for patents covering GENESA around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 129644 | ⤷ Start Trial | |
| Austria | 159710 | ⤷ Start Trial | |
| Australia | 3008889 | ⤷ Start Trial | |
| Australia | 634152 | ⤷ Start Trial | |
| Germany | 68924661 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
